Equities research analysts expect Masco Corp (NYSE:MAS) to report sales of $2.35 billion for the current quarter, according to Zacks. Six analysts have issued estimates for Masco’s earnings, with estimates ranging from $2.34 billion to $2.35 billion. Masco reported sales of $2.30 billion during the same quarter last year, which would suggest a positive year over year growth rate of 2.2%. The company is expected to issue its next quarterly earnings report before the market opens on Thursday, July 25th.

According to Zacks, analysts expect that Masco will report full-year sales of $8.55 billion for the current year, with estimates ranging from $8.49 billion to $8.59 billion. For the next fiscal year, analysts expect that the firm will post sales of $8.85 billion, with estimates ranging from $8.72 billion to $8.93 billion. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Masco.

Masco (NYSE:MAS) last issued its quarterly earnings results on Thursday, April 25th. The construction company reported $0.44 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.47 by ($0.03). Masco had a return on equity of 675.68% and a net margin of 8.40%. The company had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.99 billion. During the same period in the prior year, the business posted $0.45 EPS. The company’s revenue for the quarter was down .6% compared to the same quarter last year.

Several equities analysts have weighed in on the company. Raymond James set a $33.00 target price on LKQ and gave the company a “buy” rating in a research note on Friday, April 26th. Zelman & Associates raised Masco from a “hold” rating to a “buy” rating in a research report on Monday, April 29th. Barclays set a $46.00 price target on D. R. Horton and gave the stock a “buy” rating in a report on Friday, April 26th. Bank of America upgraded Esperion Therapeutics from an “underperform” rating to a “neutral” rating in a research note on Monday, May 6th. Finally, Robert W. Baird assumed coverage on Rocket Pharmaceuticals in a research note on Monday, April 22nd. They issued an “outperform” rating on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $44.29.

Shares of MAS traded down $0.28 on Monday, reaching $37.57. 3,430,410 shares of the stock traded hands, compared to its average volume of 3,608,278. The stock’s 50-day moving average is $38.45. Masco has a 12 month low of $27.03 and a 12 month high of $41.00. The firm has a market cap of $11.11 billion, a price-to-earnings ratio of 15.03, a price-to-earnings-growth ratio of 1.52 and a beta of 1.46. The company has a debt-to-equity ratio of 65.98, a quick ratio of 0.91 and a current ratio of 1.43.

The company also recently declared a quarterly dividend, which will be paid on Monday, August 12th. Shareholders of record on Friday, July 12th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Thursday, July 11th. Masco’s dividend payout ratio (DPR) is presently 19.20%.

A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. grew its stake in shares of Masco by 2.8% during the 1st quarter. BlackRock Inc. now owns 26,449,910 shares of the construction company’s stock worth $1,039,744,000 after purchasing an additional 720,806 shares during the period. APG Asset Management N.V. grew its position in Masco by 1.8% in the fourth quarter. APG Asset Management N.V. now owns 7,647,312 shares of the construction company’s stock valued at $195,606,000 after acquiring an additional 133,600 shares in the last quarter. Northern Trust Corp grew its position in shares of Masco by 0.3% during the first quarter. Northern Trust Corp now owns 7,314,108 shares of the construction company’s stock worth $287,517,000 after buying an additional 24,690 shares in the last quarter. Two Sigma Advisers LP grew its position in shares of Masco by 65.3% during the fourth quarter. Two Sigma Advisers LP now owns 4,736,205 shares of the construction company’s stock worth $138,487,000 after buying an additional 1,871,100 shares in the last quarter. Finally, Two Sigma Investments LP boosted its holdings in Masco by 91.3% in the fourth quarter. Two Sigma Investments LP now owns 4,293,665 shares of the construction company’s stock worth $125,547,000 after purchasing an additional 2,049,065 shares during the period. Hedge funds and other institutional investors own 90.03% of the company’s stock.

Masco Company Profile

Masco Corporation designs, manufactures, and distributes home improvement and building products worldwide. The company's Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, toilets, acrylic tubs, shower trays, spas, exercise pools, fitness systems, and other non-decorative plumbing products; brass, copper, and composite plumbing system components; and thermoplastic extrusions, extruded plastic profiles, and specialized fabrications.

Read More: What are momentum indicators and what do they show?

Get a free copy of the Zacks research report on Masco (MAS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Masco (NYSE:MAS)

Receive News & Ratings for Masco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masco and related companies with MarketBeat.com's FREE daily email newsletter.